EBR Systems Inc Total Liabilities
EBR Systems Inc total liabilities. Based on the latest financial reports, EBR Systems Inc (EBR) has total liabilities worth AU$71.69 Million AUD (≈ $50.72 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check EBR Systems Inc (EBR) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of EBR Systems Inc (2019–2025)
Total liabilities of EBR Systems Inc from 2019 to 2025. This chart illustrates how EBR Systems Inc's total liabilities have evolved over time, based on quarterly financial data. Explore EBR Systems Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
EBR Systems Inc Competitors by Total Liabilities
The table below lists competitors of EBR Systems Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Groupe Partouche SA
PA:PAR
|
France | €100.64 Million |
|
M.J. International Co Ltd
TW:8466
|
Taiwan | NT$3.28 Billion |
|
Grandstand Limited
NASDAQ:GRSD
|
USA | $179.78 Million |
|
City Of London Investment Trust
LSE:CTY
|
UK | GBX164.23 Million |
|
Regal Holding Co Ltd
TW:4807
|
Taiwan | NT$940.14 Million |
|
Bluerock Homes Trust Inc.
NYSE MKT:BHM
|
USA | $452.66 Million |
|
INmune Bio Inc
NASDAQ:INMB
|
USA | $6.48 Million |
|
Smr Utama Tbk
JK:SMRU
|
Indonesia | Rp682.09 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down EBR Systems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is EBR Systems Inc's balance sheet.
Liquidity & Leverage Metrics
EBR Systems Inc Total Liabilities Ratios Explained
EBR Systems Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.41 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.74 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how EBR Systems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for EBR Systems Inc (2019–2025)
The table below shows the annual total liabilities of EBR Systems Inc from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | AU$71.69 Million ≈ $50.72 Million |
+45.69% |
| 2024-12-31 | AU$49.20 Million ≈ $34.81 Million |
+2.85% |
| 2023-12-31 | AU$47.84 Million ≈ $33.85 Million |
+72.53% |
| 2022-12-31 | AU$27.73 Million ≈ $19.62 Million |
+191.09% |
| 2021-12-31 | AU$9.53 Million ≈ $6.74 Million |
-79.31% |
| 2020-12-31 | AU$46.05 Million ≈ $32.58 Million |
+75.67% |
| 2019-12-31 | AU$26.21 Million ≈ $18.55 Million |
-- |
About EBR Systems Inc
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization thera… Read more